Acurx Pharmaceuticals files for secondary offering
Source: SeekingAlpha
2025-01-31 16:28:10 ET
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q3 2024 Earnings Call Transcript
- Acurx Pharmaceuticals announces $2.5 million registered direct offering
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
- Historical earnings data for Acurx Pharmaceuticals
- Financial information for Acurx Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Acurx Pharmaceuticals files for secondary offering
Acurx Pharmaceuticals Inc.
NASDAQ: ACXP
ACXP Trading
-9.1% G/L:
$4.076 Last:
4,599,864 Volume:
$4.24 Open:
ACXP Latest News
March 13, 2026 07:01:00 am
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
ACXP Stock Data
$5,246,237
2,029,733
5.06%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Staten Island
